Filterable duocarmycin-containing antibody-drug conjugate compositions and related methods
WO2018215427A1
Dual conjugation process for preparing antibody-drug conjugates
BR112019023754A2
anti-sirpalpha antibody or antigen-binding fragment thereof, pharmaceutical composition, and combination of anti-sirpalpha antibody or pharmaceutical composition.
WO2018069375A1
Non-linear self-immolative linkers and conjugates thereof
CN108348608A
Anti- 5T4 antibody and antibody-drug conjugates
WO2017050846A1
Syd985 treatment of t-dm1 refractory cancer patients
CN107847449A
Include the composition of antibody times carcinomycin drug conjugate
EP3197919A1
Pan-reactive antibodies to duocarmycins
EP3539544A1
Site-specific conjugation of linker drugs to antibodies and resulting adcs
SG11201605602XA
Duocarmycin adcs showing improved in vivo antitumor activity
CA2935456A1
Method for purifying cys-linked antibody-drug conjugates
EP3152191A1
Improved process for making duocarmycin prodrugs
EP2791170A1
Compounds and methods for treating inflammatory diseases
EP2721160A2
Compositions and methods for making and biocontaining auxotrophic transgenic plants
